Cytek Biosciences Inc

27 sie 2026, 20:07 UTC

Cytek Biosciences Inc shares are higher, reflecting a positive trend since Wednesday. A decline in jobless claims supports the favorable market backdrop.

25 sie 2026, 19:26 UTC

Cytek Biosciences Inc is trading higher during Tuesday's session, reflecting a stable backdrop amid rising U.S. Treasury yields that support equity valuations.

24 sie 2026, 20:01 UTC

Cytek Biosciences Inc. shares are trading lower amid a broader market decline and geopolitical concerns over U.S. sanctions on Iran affecting oil supply.

21 sie 2026, 22:01 UTC

Cytek Biosciences shares are lower in after-market hours following a jury's $56 million damages award to Beckman Coulter for patent infringement.

19 sie 2026, 19:26 UTC

Cytek Biosciences Inc shares are higher today, reaching an intraday high before retracing slightly. The stock remains above its 20-day moving average.

18 sie 2026, 19:46 UTC

Cytek Biosciences Inc shares are lower today, reaching a session low earlier. Rising Treasury yields amid inflation concerns may be affecting investor sentiment.

14 sie 2026, 20:02 UTC

Cytek Biosciences shares declined during Friday's session, following a broader market trend after U.S. retail sales unexpectedly fell in July.

13 sie 2026, 19:51 UTC

Cytek Biosciences Inc shares are advancing, reflecting a cumulative gain over seven sessions. No specific company news was identified to explain the movement.

12 sie 2026, 20:06 UTC

Cytek Biosciences Inc. shares are roughly flat during Wednesday's session. Broader market performance remains unchanged amid geopolitical tensions and U.S. Treasury yields.

11 sie 2026, 23:06 UTC

Cytek Biosciences Inc. shares showed little change during after-market hours, trading within a narrow range without any specific news or developments.

10 sie 2026, 19:51 UTC

Cytek Biosciences Inc shares are higher in Monday's session, continuing an upward trend since Friday. No specific news was identified to explain the movement.

7 sie 2026, 19:36 UTC

Cytek Biosciences Inc is higher today, supported by broader market gains amid expectations of a Federal Reserve pause on interest rate hikes.

6 sie 2026, 20:02 UTC

Cytek Biosciences raises 2026 revenue guidance to $207 million-$212 million, aligning with consensus. Shares are higher despite a mixed earnings report.

5 sie 2026, 22:02 UTC

Cytek Biosciences shares are lower in after-market hours following a second-quarter earnings miss and revenue that fell short of expectations.

4 sie 2026, 20:06 UTC

Cytek Biosciences Inc. shares are lower today, reflecting broader market trends after a notable early peak. Overall market performance has declined since Monday.

3 sie 2026, 19:56 UTC

Cytek Biosciences Inc. shares are higher today, reflecting broader market trends as major indices gain amid easing geopolitical tensions. No specific news was identified.

31 lip 2026, 19:26 UTC

Cytek Biosciences Inc shares are lower as first-quarter results show a significant decline, reflecting broader sector pressures amid rising bond yields.

30 lip 2026, 19:18 UTC

Cytek Biosciences Inc. shares are lower today, reflecting ongoing weakness and trading significantly below the 20-day moving average amid broader market volatility.

27 lip 2026, 19:56 UTC

Cytek Biosciences Inc is trading lower today, retracing from an early peak. The asset remains near the lower end of its one-month trading range.

24 lip 2026, 17:16 UTC

Cytek Biosciences Inc. shares are lower today, declining after an early peak. The asset remains below its 20-day moving average amid broader market volatility.

23 lip 2026, 19:46 UTC

Cytek Biosciences Inc. shares are trading roughly flat, reflecting limited movement since Wednesday. Earlier, shares peaked before retracing to current levels.

21 lip 2026, 19:06 UTC

Cytek Biosciences Inc shares are lower today, continuing a three-session decline amid broader market conditions. No specific news was identified to explain the movement.

20 lip 2026, 19:06 UTC

Cytek Biosciences Inc. shares are lower today, reflecting routine fluctuations near the upper end of their one-month trading range amid a broader market decline.